Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM

Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Are Visual Deficits After Stroke Being Missed?

Is Stroke Underrecognized After Snakebite?

Gear Up Now for Daylight Savings Time: Five Steps

Low-Risk TAVR Matches SAVR at 6 Years; Reinterventions Rise

Bannwarth Syndrome in a Woman With Early Breast Cancer

FDA approves next-generation CardioMEMS reader for heart failure monitoring

Aardvark Pauses Late-stage Trial Testing Rare Disease Treatment

Bariatric Surgery Beats GLP-1s for Heart Protection in T2D